A detailed history of Quest Partners LLC transactions in Organon & Co. stock. As of the latest transaction made, Quest Partners LLC holds 38,941 shares of OGN stock, worth $567,759. This represents 0.07% of its overall portfolio holdings.

Number of Shares
38,941
Previous 10,070 286.7%
Holding current value
$567,759
Previous $208 Million 257.37%
% of portfolio
0.07%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$18.65 - $23.03 $538,444 - $664,899
28,871 Added 286.7%
38,941 $745 Million
Q2 2024

Aug 06, 2024

BUY
$17.45 - $21.96 $144,119 - $181,367
8,259 Added 456.05%
10,070 $208 Million
Q1 2024

May 09, 2024

SELL
$13.78 - $18.8 $135,195 - $184,446
-9,811 Reduced 84.42%
1,811 $34 Million
Q4 2023

Feb 09, 2024

BUY
$10.95 - $17.32 $127,260 - $201,293
11,622 New
11,622 $168 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.71B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.